Aisling Capital

Summary

Aisling Capital is the famous VC, which was founded in 2000. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the New York.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Aisling Capital, startups are often financed by Vivo Capital, New Enterprise Associates, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, New Enterprise Associates, Venrock. In the next rounds fund is usually obtained by OrbiMed, Kearny Venture Partners, Polaris Partners.

The top amount of exits for fund were in 2014. The top activity for fund was in 2013. Despite it in 2019 the fund had an activity. The average startup value when the investment from Aisling Capital is 100-500 millions dollars. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Aisling Capital performs on 12 percentage points more the average number of lead investments.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Loxo Oncology, Zeltiq Aesthetics, BridgeBio We can highlight the next thriving fund investment areas, such as Therapeutics, Medical.

We also calculated 7 valuable employees in our database.